SITAGLIPTIN/METFORMIN
Active Ingredient: SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE), METFORMIN HYDROCHLORIDE
Product Overview
About SITAGLIPTIN/METFORMIN
SITAGLIPTIN/METFORMIN is a prescription medication containing the active ingredients SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) and METFORMIN HYDROCHLORIDE. It is used in the treatment of type 2 diabetes mellitus, specifically to improve glycemic control and reduce the risk of cardiovascular events.
Key Benefits & Uses
- Improves glycemic control in patients with type 2 diabetes mellitus
- Reduces the risk of major adverse cardiovascular events (MACE) in patients with type 2 diabetes mellitus and established cardiovascular disease
- May be used in combination with other medications to improve blood sugar control and reduce the risk of cardiovascular events
Active Ingredient & Action
SITAGLIPTIN (SITAGLIPTIN PHOSPHATE MONOHYDRATE) is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by increasing the levels of incretin hormones, which help to stimulate the release of insulin and decrease the release of glucagon. METFORMIN HYDROCHLORIDE is a biguanide that works by decreasing glucose production in the liver and increasing insulin sensitivity. Together, these mechanisms help to lower blood sugar levels and improve glycemic control.
Important Notes
SITAGLIPTIN/METFORMIN should be used under the guidance of a healthcare professional. It is essential to follow the recommended dosage and usage instructions to minimize the risk of side effects. Patients with kidney disease, liver disease, or a history of pancreatitis should use this medication with caution and under close medical supervision. Regular monitoring of blood sugar levels and kidney function is recommended while taking SITAGLIPTIN/METFORMIN.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
